Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pemvidutide
pemvidutide
Altimmune completes dosing in MOMENTUM trial to treat obesity
Altimmune completes dosing in MOMENTUM trial to treat obesity
Clinical Trials Arena
Altimmune
clinical trials
pemvidutide
obesity
Flag link:
Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist
Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist
Fierce Biotech
Altimmune
NASH
clinical trials
pemvidutide
Flag link:
Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy
Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy
Seeking Alpha
Altimmune
clinical trials
obesity
pemvidutide
Flag link:
